Alkaline Phosphatase As a Marker for Painful Vaso-Occlusive Events and Other Acute Complications in Sickle Cell Disease

British Journal of HaematologyEarly View LETTER TO THE EDITOR Alkaline phosphatase as a marker for painful vaso-occlusive events and other acute complications in sickle cell disease Jin Han, Corresponding Author Jin Han [email protected] orcid.org/0000-0003-0662-006X Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois, USA Division of Hematology & Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA Correspondence Jin Han, Department of Pharmacy Practice, College of Pharmacy University of Illinois at Chicago, 833 South Wood Street, Suite 164, Chicago, IL, USA. Email: [email protected]Search for more papers by this authorXu Zhang, Xu Zhang Division of Hematology & Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, USASearch for more papers by this authorBinal N. Shah, Binal N. Shah Division of Hematology & Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, USASearch for more papers by this authorSantosh L. Saraf, Santosh L. Saraf orcid.org/0000-0002-8584-4194 Division of Hematology & Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, USASearch for more papers by this authorVictor R. Gordeuk, Victor R. Gordeuk Division of Hematology & Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, USASearch for more papers by this author Jin Han, Corresponding Author Jin Han [email protected] orcid.org/0000-0003-0662-006X Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Chicago, Illinois, USA Division of Hematology & Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, USA Correspondence Jin Han, Department of Pharmacy Practice, College of Pharmacy University of Illinois at Chicago, 833 South Wood Street, Suite 164, Chicago, IL, USA. Email: [email protected]Search for more papers by this authorXu Zhang, Xu Zhang Division of Hematology & Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, USASearch for more papers by this authorBinal N. Shah, Binal N. Shah Division of Hematology & Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, USASearch for more papers by this authorSantosh L. Saraf, Santosh L. Saraf orcid.org/0000-0002-8584-4194 Division of Hematology & Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, USASearch for more papers by this authorVictor R. Gordeuk, Victor R. Gordeuk Division of Hematology & Oncology, Department of Medicine, University of Illinois at Chicago, Chicago, Illinois, USASearch for more papers by this author First published: 21 May 2024 https://doi.org/10.1111/bjh.19554Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Makris K, Mousa C, Cavalier E. Alkaline phosphatases: biochemistry, functions, and measurement. Calcif Tissue Int. 2023; 112: 233–242. 10.1007/s00223-022-01048-x CASPubMedWeb of Science®Google Scholar 2Masrour Roudsari J, Mahjoub S. Quantification and comparison of bone-specific alkaline phosphatase with two methods in normal and paget's specimens. Caspian J Intern Med. 2012; 3: 478–483. PubMedGoogle Scholar 3Nouraie M, Cheng K, Niu X, Moore-King E, Fadojutimi-Akinsi MF, Minniti CP, et al. Predictors of osteoclast activity in patients with sickle cell disease. Haematologica. 2011; 96: 1092–1098. 10.3324/haematol.2011.042499 CASPubMedGoogle Scholar 4Brody JI, Ryan WN, Haidar MA. Serum alkaline phosphatase isoenzymes in sickle cell anemia. JAMA. 1975; 232: 738–741. 10.1001/jama.1975.03250070034021 CASPubMedWeb of Science®Google Scholar 5Feld JJ, Kato GJ, Koh C, Shields T, Hildesheim M, Kleiner DE, et al. Liver injury is associated with mortality in sickle cell disease. Aliment Pharmacol Ther. 2015; 42: 912–921. 10.1111/apt.13347 CASPubMedWeb of Science®Google Scholar 6Curtis SA, Danda N, Etzion Z, Cohen HW, Billett HH. Longitudinal analysis of patient specific predictors for mortality in sickle cell disease. PLoS One. 2016; 11:e0164743. 10.1371/journal.pone.0164743 PubMedWeb of Science®Google Scholar 7Sachdev V, Tian X, Gu Y, Nichols J, Sidenko S, Li W, et al. A phenotypic risk score for predicting mortality in sickle cell disease. Br J Haematol. 2021; 192: 932–941. 10.1111/bjh.17342 PubMedWeb of Science®Google Scholar 8Alagbe AE, Olaniyi JA, Aworanti OW. Adult sickle cell Anaemia patients in bone pain crisis have elevated pro-inflammatory cytokines. Mediterr J Hematol Infect Dis. 2018; 10:e2018017. 10.4084/mjhid.2018.017 PubMedWeb of Science®Google Scholar 9Saraf SL, Molokie RE, Nouraie M, Sable CA, Luchtman-Jones L, Ensing GJ, et al. Differences in the clinical and genotypic presentation of sickle cell disease around the world. Paediatr Respir Rev. 2014; 15: 4–12. 10.1016/j.prrv.2013.11.003 PubMedWeb of Science®Google Scholar 10Koh C, Turner T, Zhao X, Minniti CP, Feld JJ, Simpson J, et al. Liver stiffness increases acutely during sickle cell vaso-occlusive crisis. Am J Hematol. 2013; 88: E250–E254. 10.1002/ajh.23532 PubMedWeb of Science®Google Scholar Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation